Cannabis Products Insights

May 24, 2022

View Archived Issues --Please Select-- May 17, 2022 May 10, 2022 May 3, 2022 April 26, 2022 April 19, 2022 March 29, 2022 March 15, 2022 March 8, 2022 March 1, 2022 February 15, 2022 February 8, 2022 February 1, 2022 January 25, 2022 January 18, 2022 January 11, 2022 January 4, 2022 December 28, 2021 December 21, 2021 December 7, 2021 November 30, 2021 November 23, 2021 November 16, 2021 November 9, 2021 November 2, 2021 October 26, 2021 October 19, 2021 October 12, 2021 October 5, 2021 September 28, 2021 September 21, 2021 September 14, 2021 September 7, 2021 August 31, 2021 August 24, 2021 August 17, 2021 August 10, 2021 July 27, 2021 July 20, 2021 July 13, 2021 July 6, 2021 June 29, 2021 June 22, 2021 June 15, 2021 June 8, 2021 June 1, 2021 May 25, 2021 May 18, 2021 May 11, 2021 May 4, 2021 April 27, 2021 April 20, 2021 April 13, 2021 April 6, 2021 March 30, 2021 March 23, 2021 March 16, 2021 March 9, 2021 March 2, 2021 February 23, 2021 February 16, 2021 February 9, 2021 February 2, 2021 January 26, 2021 January 19, 2021 January 12, 2021 January 5, 2021 December 29, 2020 December 22, 2020 December 15, 2020 December 8, 2020 December 1, 2020 November 24, 2020 November 17, 2020 November 10, 2020 November 3, 2020 October 27, 2020 October 20, 2020 October 13, 2020 October 6, 2020 September 29, 2020 September 22, 2020 September 15, 2020 September 8, 2020 September 1, 2020 August 25, 2020 August 18, 2020 August 11, 2020 August 4, 2020 July 28, 2020 July 21, 2020 July 14, 2020 July 7, 2020 June 30, 2020 June 18, 2020 June 9, 2020 June 2, 2020 May 26, 2020 May 19, 2020 May 12, 2020 May 5, 2020 April 28, 2020 April 14, 2020 April 7, 2020 March 31, 2020 March 24, 2020 March 17, 2020 March 10, 2020 March 3, 2020 February 25, 2020 February 18, 2020 February 11, 2020 February 4, 2020

FDA Launches Aggressive ‘Cannabis-Derived Products’ Study Protocol

With cannabis-derived products outpacing the existing science and imposing massive health concerns, in October 2021 the FDA issued a “Cannabis-derived products data acceleration plan” to detect safety signals and accelerate research studies.

Read More

Boston Beer Company to Launch Teapot THC Tea in Canada

The brand’s first release is a Good Day Iced Tea, made with lemon black tea and infused with Pedro's Sweet Sativa, a unique cultivar grown in Strathroy, Ontario.

Read More

Joy Organics Launches Budder THC Gummies

Both gummy formulas will contain 25 mg CBD, 2 mg CBG, and other naturally-occurring cannabinoids.

Read More

Theory Wellness Debuts Hi5 Energy

Each can of Hi5 Energy contains 5 mg THC and approximately 80 mg of caffeine, which is roughly equivalent to a cup of coffee.

Read More

An Inside Look at Cann’s Approach to Product Development

Co-founder and CEO Jake Bullock offered insight into Cann’s genesis and the company’s approach to product development during his keynote presentation for Cannabis Products Exchange, held April 28-29 at the Hilton Denver City Center.

Read More

2022 State of the Cannabis-Infused Food and Beverage Industry: Steadily Expanding

The overall cannabis market across legalized U.S. state markets is valued at $25 billion, with 40% sales growth for 2021. Cannabis-infused foods and beverages have also seen strong growth. Read More

Vertosa to Partner with UMass Amherst on CBG Studies

Vertosa has entered into a research partnership with the University of Massachusetts Amherst to support the university’s studies regarding the nutritional applications and diet interactions of CBG.

Read More

Rootwurks Introduces Cannabis Training and Compliance Platform

Rootwurks, Inc. has launched an e-learning, training, and compliance management platform to help cannabis companies maintain regulatory compliance through interactive education and a user-friendly operational toolkit.

Read More

Washington Grants Flowe Technology the State’s Second Research License

By securing a state-approved cannabis research license, Flowe Technology will actively study the effects of cannabis products on consumers.

Read More